Blood Pressure MATTERS Act
- Bill Number
- H.R. 8716
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2026-05-07: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2026-05-21T18:27:19Z
AI-Generated Summary
Purpose
The Blood Pressure MATTERS Act (H.R. 8716) requires health coverage programs to provide free access to validated home blood pressure monitors for pregnant and postpartum people. This aims to help detect high blood pressure early, reducing risks like preeclampsia (a serious pregnancy complication involving dangerously high blood pressure) and eclampsia (seizures caused by preeclampsia).
Key Provisions
- Coverage Requirement: All qualified health plans must cover self-measured blood pressure monitoring, defined as supplying one FDA-approved (via 510(k) clearance), self-usable device listed as validated by the American Medical Association's website.
- Applies during pregnancy and up to 12 months postpartum (or longer for certain Medicaid-eligible individuals).
- Limited to one device every 2 years.
- No requirement for a diagnosed hypertensive (high blood pressure) disorder.
- No Cost-Sharing: Patients pay nothing out-of-pocket (no copays, deductibles, or coinsurance).
- Affected Programs:
| Program | Details | |---------|---------| | Medicaid (Title XIX, Social Security Act) | Mandatory benefit; added to covered services list. | | CHIP (Title XXI, for pregnancy-related aid) | Required for targeted low-income pregnant women. | | Private Insurance (PHSA, ERISA, IRC) | Group and individual plans must cover; applies to plan years starting 120 days post-enactment. |
- Effective Date: Generally 120 days after enactment; states get extra time if legislation is needed.
Significant Changes to Existing Law
- Adds New Mandatory Benefits: Introduces blood pressure devices as a required service in Medicaid/CHIP (previously optional) and private plans (no prior federal mandate).
- Expands Postpartum Coverage: Extends beyond typical pregnancy periods in public programs.
- Standardizes Device Criteria: First federal rule tying coverage to AMA validation and FDA clearance.
- Bans Diagnosis Prerequisite and Fees: Explicitly prohibits these barriers, unlike some current optional coverages.
Potential Impacts
- On Citizens: Pregnant/postpartum individuals (especially low-income) gain free, easy home monitoring, potentially improving health outcomes and reducing emergency visits.
- On Government Agencies: States must update Medicaid/CHIP plans (HHS oversees); may increase federal Medicaid spending.
- On Insurers/Employers: Private plans face new costs but limited by one-device cap; could standardize maternal care.
- Healthcare System: Boosts preventive care; minimal device makers' burden (only validated products qualify).
- No direct impact on international relations.
Main Stakeholders
- Pregnant/Postpartum Individuals: Primary beneficiaries, particularly Medicaid/CHIP users.
- Health Insurers and Group Plans: Must comply and cover costs.
- State Governments: Administer public programs; may need new laws.
- Device Manufacturers: Only FDA-cleared, AMA-validated products qualify.
- Healthcare Providers: Support monitoring without added visits.
- Federal Agencies: HHS (enforcement), AMA (device listing).
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens maternal health mandates under existing frameworks (e.g., commerce clause for insurance); enforceable via HHS audits/penalties.
- Constitutional: Aligns with federal spending power (Medicaid) and interstate commerce regulation (private insurance).
- Political: Advances health equity for maternal mortality (disproportionately affects certain groups); may spark debate on federal overreach into insurance/state programs. No funding appropriated—relies on existing budgets.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Williams, Nikema [D-GA-5]
Cosponsors (5)
Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Wilson, Frederica S. [D-FL-24], Rep. Beatty, Joyce [D-OH-3], Rep. Ross, Deborah K. [D-NC-2], Rep. Tlaib, Rashida [D-MI-12]
Recent Actions
- 2026-05-07: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2026-05-07: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2026-05-07: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2026-05-07: Introduced in House
- 2026-05-07: Introduced in House
Bill Versions
- Blood Pressure Mandated Accessible Telemetry Tracking for Eclampsia Risk Safeguards Act — issued 2026-05-07 — PDF (13 pages)